Phase 1 BIO 300 Oral Suspension

NCT06741345 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer Study

Interventions

DRUG: BIO 300 Oral Suspension

Sponsor

Humanetics Corporation